Role of caspase-1 in nuclear translocation of IL-37, release of the cytokine, and IL-37 inhibition of innate immune responses

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2014-01-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/pnas.1324140111PMID 24481253PMCID PMC3932872
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 187: Interleukin 37 employs the IL-1 family inhibitory receptor SIGIRR and the alpha chain of the IL-18 receptor to suppress innate immunity

  2013cited by this paper
• Interleukin-18 and IL-18 Binding Protein

  2013cited by this paper
• Dendritic Cell Derived Cytokines in Human Natural Killer Cell Differentiation and Activation

  2013influential reference
• 163 : Recombinant IL-37 inhibits LPS induced inflammation in a SIGIRR- and MAPK-dependent manner

  2013cited by this paper
• Nontypeable Haemophilus Influenzae Infection Upregulates the NLRP3 Inflammasome and Leads to Caspase-1-Dependent Secretion of Interleukin-1β — A Possible Pathway of Exacerbations in COPD

  2013cited by this paper
• NLRP1 haplotypes associated with vitiligo and autoimmunity increase interleukin-1β processing via the NLRP1 inflammasome

  2013cited by this paper
• Inflammasomes in health and disease

  2012cited by this paper
• Comparison of non-crystalline silica nanoparticles in IL-1β release from macrophages

  2012cited by this paper
• Asian sand dust enhances murine lung inflammation caused by Klebsiella pneumoniae.

  2012cited by this paper
• Interleukin‐37 reduces liver inflammatory injury via effects on hepatocytes and non‐parenchymal cells

  2012cited by this paper
• IL-37: a new anti-inflammatory cytokine of the IL-1 family.

  2011cited by this paper
• Interleukin 37 expression protects mice from colitis

  2011cited by this paper
• Interleukin-36 (IL-36) Ligands Require Processing for Full Agonist (IL-36α, IL-36β, and IL-36γ) or Antagonist (IL-36Ra) Activity

  2011influential reference
• Interleukin 37 is a fundamental inhibitor of innate immunity

  2010cited by this paper
• Cholesterol Crystals Activate the NLRP3 Inflammasome in Human Macrophages: A Novel Link between Cholesterol Metabolism and Inflammation

  2010influential reference
• Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages.

  2009cited by this paper
• The IL-1 Family Member 7b Translocates to the Nucleus and Down-Regulates Proinflammatory Cytokines1

  2008cited by this paper
• Active caspase-1 is a regulator of unconventional protein secretion.

  2008influential reference
• Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization

  2008influential reference
• The NALP3 inflammasome is involved in the innate immune response to amyloid-β

  2008cited by this paper
• Cryopyrin/NALP3 binds ATP/dATP, is an ATPase, and requires ATP binding to mediate inflammatory signaling

  2007influential reference
• Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1.

  2006influential reference
• NK/iDC interaction results in IL-18 secretion by DCs at the synaptic cleft followed by NK cell activation and release of the DC maturation factor HMGB1.

  2005cited by this paper
• NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder.

  2004cited by this paper
• Interleukin-1 homologues IL-1F7b and IL-18 contain functional mRNA instability elements within the coding region responsive to lipopolysaccharide.

  2004cited by this paper
• Interleukin-1F7B (IL-1H4/IL-1F7) is processed by caspase-1 and mature IL-1F7B binds to the IL-18 receptor but does not induce IFN-gamma production.

  2002influential reference
• A complex of the IL-1 homologue IL-1F7b and IL-18-binding protein reduces IL-18 activity

  2002cited by this paper
• IL-1H, an interleukin 1-related protein that binds IL-18 receptor/IL-1Rrp.

  2001influential reference
• Interleukin-1 beta maturation and release in response to ATP and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity.

  1994influential reference

• Helicobacter pylori induces the production of interleukin-37 to promote broad immunosuppression and enhance colonization.

  2026cites this paper
• Characteristics of T-Cells Expressing IL-37 and Its Receptors in Inflammatory Bowel Disease

  2026cites this paper
• Associations between interleukin-37 gene polymorphisms and susceptibility and clinical outcomes of rheumatoid arthritis: a meta-analysis and systematic review.

  2026cites this paper
• Urinary interleukin-37 as a suggested protective biomarker of renal prognosis in autosomal dominant polycystic kidney disease.

  2026cites this paper
• Distinct and context-dependent immunobiology of interleukin (IL)-36, IL-37 and IL-38: A comparative review.

  2026cites this paper
• B cells inhibit IL-1 family cytokine production and Mycobacterium tuberculosis growth in human CD14+ cells

  2025cites this paper
• 10 things you wish you knew about inflammatory caspases: A holistic review of their biochemistry, activation, and signalling

  2025cites this paper
• AAV9-delivery of interleukin-37b gene prevents recurrent herpetic stromal keratitis via the SIGIRR pathway in mice.

  2025cites this paper
• The expanding role of the NLRP3 inflammasome from periodic fevers to therapeutic targets

  2025cites this paper
• Interleukin-37 modulates microglial phenotype and inhibits inflammatory response via the MyD88/NF-κB pathway in lipopolysaccharide-induced neuroinflammation

  2025cites this paper
• Interleukin-37 in respiratory diseases: molecular mechanisms and immune modulation

  2025cites this paper
• IL-37 Alleviates Sepsis-Induced Lung Injury by Inhibiting Inflammatory Response Through the TGF-β/Smad3 Pathway

  2025cites this paper
• The Potential Contribution of the IL-37/IL-18/IL-18BP/IL-18R Axis in the Pathogenesis of Sjögren’s Syndrome

  2025cites this paper
• The role of IL-37 and IL-38 in rheumatoid arthritis, the potential clinical applications in precision medicine

  2025cites this paper
• Cellular and Molecular Mechanisms of Innate Memory Responses.

  2025cites this paper
• The stress and the alarmin-like cytokine interleukin-37 mediated extracellular and intracellular signal pathways.

  2025cites this paper
• IL-37/IL-1R8 axis: a novel major mechanism of control at the interface between tumor and immune cells

  2025influential citation
• Inflammatory caspase substrate specificities

  2024cites this paper
• Interleukin-37: a new therapeutic target in autosomal dominant polycystic kidney disease.

  2024cites this paper
• Recombinant expression, downstream optimization, and therapeutic evaluation of recombinant human interleukin-37 for cancer therapy

  2024influential citation
• Inflammasome components as new therapeutic targets in inflammatory disease

  2024cites this paper
• Advanced glycation end product-modified low-density lipoprotein promotes pro-osteogenic reprogramming via RAGE/NF-κB pathway and exaggerates aortic valve calcification in hamsters

  2024cites this paper
• Anti-Inflammatory Effect of Atorvastatin and Rosuvastatin on Monosodium Urate-Induced Inflammation through IL-37/Smad3-Complex Activation in an In Vitro Study Using THP-1 Macrophages

  2024cites this paper
• Comprehensive Insights into Keloid Pathogenesis and Advanced Therapeutic Strategies

  2024cites this paper
• IL-37 alleviates TNF-α-induced pyroptosis of rheumatoid arthritis fibroblast-like synoviocytes by inhibiting the NF-κB/GSDMD signaling pathway.

  2023cites this paper
• Deregulated Expression of IL-37 in Patients with Bladder Urothelial Cancer: The Diagnostic Potential of the IL-37e Isoform

  2023cites this paper
• The nuclear cytokine IL-37a controls lethal cytokine storms primarily via IL-1R8-independent transcriptional upregulation of PPARγ

  2023cites this paper
• Modulation of intestinal IL-37 expression and its impact on the epithelial innate immune response and barrier integrity

  2023cites this paper
• An updated review of the immunological mechanisms of keloid scars

  2023cites this paper
• Uncoupled pyroptosis and IL-1β secretion downstream of inflammasome signaling

  2023cites this paper
• Immune and inflammatory mechanisms and therapeutic targets of gout: An update.

  2023cites this paper
• Interleukin 37 Regulates Glycolysis by Inhibiting Glucose Transporter 1 Expression in Lung Adenocarcinoma

  2023cites this paper
• IL-37 Ameliorates Renal Fibrosis by Restoring CPT1A-Mediated Fatty Acid Oxidation in Diabetic Kidney Disease

  2023cites this paper
• IL-37 counteracts inflammatory injury in the temporomandibular joint via the intracellular pathway

  2023cites this paper
• Cell Intrinsic IL-38 Affects B Cell Differentiation and Antibody Production

  2023cites this paper
• Modulating inflammation with interleukin 37 treatment ameliorates murine Autosomal Dominant Polycystic Kidney Disease.

  2023cites this paper
• Regulatory Mechanism of the IL-33–IL-37 Axis via Aryl Hydrocarbon Receptor in Atopic Dermatitis and Psoriasis

  2023cites this paper
• The effect of levofloxacin ointment against imiquimod induced–psoriasis in mice model

  2023influential citation
• Recombinant IL-37 Exerts an Anti-inflammatory Effect on Human Aortic Valve Interstitial Cells through Extracellular and Intracellular Actions

  2023influential citation
• Novel insights into IL-37: an anti-inflammatory cytokine with emerging roles in anti-cancer process

  2023cites this paper
• Thirteen years to get from b to a: one of the neglected isoforms of IL-37 enters the stage

  2023cites this paper
• Interleukin-35 and Interleukin-37 anti-inflammatory effect on inflammatory bowel disease: Application of non-coding RNAs in IBD therapy.

  2023cites this paper
• Interleukin-37: A Link Between COVID-19, Diabetes, and the Black Fungus

  2022cites this paper
• The IL-1 Family and Its Role in Atherosclerosis

  2022cites this paper
• Myeloid cell–derived proteases produce a proinflammatory form of IL-37 that signals via IL-36 receptor engagement

  2022cites this paper
• Association between IL-37 gene variants (rs4241122 and rs2723186) and Graves’ disease risk Journal of Clinical Images and Medical Case Reports

  2022cites this paper
• Aberrant Expression and Prognostic Potential of IL-37 in Human Lung Adenocarcinoma

  2022cites this paper
• IL-37 improves mice myocardial infarction via inhibiting YAP-NLRP3 signaling mediated macrophage programming.

  2022cites this paper
• Interleukin-37 exacerbates experimental colitis in an intestinal microbiome-dependent fashion

  2022cites this paper
• The IL-18/IL-18R1 signalling axis: Diagnostic and therapeutic potential in hypertension and chronic kidney disease.

  2022cites this paper
• Association between IL-37 and VEGF Gene Expression in Psoriasis Pathogenesis in Egyptian Population

  2022cites this paper
• Interleukin-37, vascular endothelial growth factor A, and transforming growth factor-β1: promising biomarkers in primary immune thrombocytopenia

  2022cites this paper
• NLRP3 inflammasome triggers interleukin‐37 release from human monocytes

  2022cites this paper
• Recent Advances in Progresses and Prospects of IL-37 in Central Nervous System Diseases

  2022cites this paper
• Expression of IL-37 Correlates With Immune Cell Infiltrate and Fibrosis in Pediatric Autoimmune Liver Diseases

  2022cites this paper
• Diverse Control Mechanisms of the Interleukin-1 Cytokine Family

  2022cites this paper
• The Interleukin-1 (IL-1) Superfamily Cytokines and Their Single Nucleotide Polymorphisms (SNPs)

  2022cites this paper
• The intellectual base and research fronts of IL-37: A bibliometric review of the literature from WoSCC

  2022cites this paper
• IL-37 alleviates liver granuloma caused by Schistosoma japonicum infection by inducing alternative macrophage activation

  2022cites this paper
• Great balls of fire: activation and signalling of inflammatory caspases

  2021cites this paper
• Correlation Between Level of Interleukin-37 and Rheumatoid Arthritis Progression

  2021cites this paper
• Deregulation of IL-37 and its miRNAs modulators in sarcopenic patients after rehabilitation

  2021cites this paper
• Reduced CXCL1 production by endogenous IL-37 expressing dendritic cells does not affect T cell activation

  2021cites this paper
• The anti-inflammatory cytokine interleukin-37 is an inhibitor of trained immunity.

  2021cites this paper
• The emerging role of Interleukin 37 in bone homeostasis and inflammatory bone diseases.

  2021cites this paper
• IL-37 Confers Anti-Tumor Activity by Regulation of m6A Methylation

  2021cites this paper
• Role for IL-1 Family Cytokines in Fungal Infections

  2021cites this paper
• IL-37 exerts therapeutic effects in experimental autoimmune encephalomyelitis through the receptor complex IL-1R5/IL-1R8

  2021cites this paper
• Modulation of Liver Inflammation and Fibrosis by Interleukin-37

  2021cites this paper
• Association of TNFRII polymorphisms and IL-37 in rheumatoid arthritis Iraqi patients

  2021cites this paper
• IL-38 Ablation Reduces Local Inflammation and Disease Severity in Experimental Autoimmune Encephalomyelitis

  2021cites this paper
• IL-33, IL-37, and Vitamin D Interaction Mediate Immunomodulation of Inflammation in Degenerating Cartilage

  2021cites this paper
• IL-1 Family Antagonists in Mouse and Human Skin Inflammation

  2021cites this paper
• Current Understanding of IL-37 in Human Health and Disease

  2021cites this paper
• Activation of CpG-ODN-Induced TLR9 Signaling Inhibited by Interleukin-37 in U937 Human Macrophages

  2021cites this paper
• Protein engineering of a stable and potent anti-inflammatory IL-37-Fc fusion with enhanced therapeutic potential.

  2021cites this paper
• Chloroquine and Rapamycin Augment Interleukin-37 Expression via the LC3, ERK, and AP-1 Axis in the Presence of Lipopolysaccharides

  2020cites this paper
• IL-37 Represses the Autoimmunity in Myasthenia Gravis via Directly Targeting Follicular Th and B Cells

  2020cites this paper
• Priming is dispensable for NLRP3 inflammasome activation in human monocytes

  2020influential citation
• Low expression of IL-37 protein is correlated with high Oct4 protein expression in hepatocellular carcinoma.

  2020cites this paper
• Pyroptosis: The missing puzzle among innate and adaptive immunity crosstalk

  2020cites this paper
• Parsing the IL-37-Mediated Suppression of Inflammasome Function

  2020cites this paper
• Correlation between serum IL 37 levels with keloid severity.

  2020cites this paper
• A new target for the treatment of inflammatory bowel disease: Interleukin-37.

  2020cites this paper
• Interleukin-37 regulates innate immune signaling in human and mouse colonic organoids

  2020cites this paper
• Association between Serum IL-37 and Spinal Cord Injury: A Prospective Observational Study

  2020cites this paper
• Complementary regulation of caspase-1 and IL-1β reveals additional mechanisms of dampened inflammation in bats

  2020cites this paper
• Extracellular and nuclear roles of IL-37 after spinal cord injury.

  2020cites this paper
• Affimers as an alternative to antibodies for protein biomarker enrichment.

  2020cites this paper
• The potential role of interleukin-37 in infectious diseases

  2020influential citation
• IL-37 inhibits M1-like macrophage activation to ameliorate temporomandibular joint inflammation through the NLRP3 pathway.

  2020cites this paper
• Clinical Applications of Interleukin-37: A Key Player in the Immunopathogenesis of Immune Disorders.

  2020influential citation
• IL-37 as a potential biotherapeutics of inflammatory diseases.

  2020cites this paper
• IL-36 family cytokines in protective versus destructive inflammation.

  2020cites this paper
• Evolution, role in inflammation, and redox control of leaderless secretory proteins

  2020cites this paper
• The role of IL-37 in skin and connective tissue diseases.

  2019cites this paper
• In Silico and In Vivo Analysis of IL37 in Multiple Sclerosis Reveals Its Probable Homeostatic Role on the Clinical Activity, Disability, and Treatment with Fingolimod

  2019cites this paper
• PG102 Upregulates IL-37 through p38, ERK, and Smad3 Pathways in HaCaT Keratinocytes

  2019cites this paper
• Insight into interleukin-37: The potential therapeutic target in allergic diseases.

  2019cites this paper
• IL-36, IL-37, and IL-38 Cytokines in Skin and Joint Inflammation: A Comprehensive Review of Their Therapeutic Potential

  2019cites this paper